Eli Lilly & Co. (LLY)
982.22
-15.37
(-1.54%)
USD |
NYSE |
Dec 09, 16:00
985.50
+3.28
(+0.33%)
Pre-Market: 08:52
Eli Lilly Market Cap: 879.11B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.00B |
| Regeneron Pharmaceuticals, Inc. | 72.79B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 4.214B |
| Moderna, Inc. | 11.03B |
Market Cap Related Metrics
| PE Ratio | 48.58 |
| PS Ratio | 15.07 |
| PEG Ratio | 0.4009 |
| Price to Book Value | 36.95 |
| Price to Free Cash Flow | 139.13 |
| Price | 982.22 |
| Earnings Yield | 2.06% |
| PEGY Ratio | 0.3988 |
| Operating PE Ratio | 33.93 |
| Normalized PE Ratio | 43.50 |